APOTHEEK VAN EYNDE
Board
2 directors, no change since 2024Director (not named in the articles), permanent representative
since 27-02-2024
term until 11-05-2029
listed in the 2025 annual accounts, filed on 27-05-2026
Director
since 27-02-2024
term until the 2029 general meeting
listed in the 2025 annual accounts, filed on 27-05-2026
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDirector
Director
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
-
- Director, from before 15-12-2015 to 22-06-2020
- Director, from 27-02-2024 to date
-
- Director, from before 15-12-2015 to 27-02-2024
- Managing director, from before 15-12-2015, last mentioned in 2015
Control
Parent
Equity €640,851
Profit €19,116 in 2023 (profit €54,301 in 2022)
Source: accounts 2022
99.92%
This company
APOTHEEK VAN EYNDE
Equity €564,409
Profit €35,078 in 2025
Capital
- Capital
- €80,600
- Shares
- 1,250 in the deed of 22-06-2020
- Source
- deed of 21-03-2024
Owners through the years
as the annual accounts name themOwners as a list
-
- 2006 to 2008: 99.92%
- 2009 to 2018: 99.99%
- 2020 to 2022: 99.92%
Source: lists of holdings in the owners' accounts
Articles of association
deed of 22-06-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of May at 20:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle verrichtingen vermeld in wet, tenzij algemene vergadering anders besluit bij gewone meerderheid”
Capital transactions
Capital over time
- 21-03-2024 Capital increase · to €80,600
- 22-06-2020 Capital stated in the deed · €62,000 · 1,250 shares